Role of GABAA receptors in cognition

Neuronal Oscillations in Cortical Networks

Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576 · see citing works

Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations

Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050 · see citing works

Benzodiazepine Receptor: Demonstration in the Central Nervous System

Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,709 · see citing works

Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172 · see citing works

Neurosteroids: endogenous regulators of the GABAA receptor

Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159 · see citing works

Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring

Stephan, K. E., Friston, K. J., & Frith, C. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn176 · Cited by 1,134 · see citing works

Molecular and neuronal substrate for the selective attenuation of anxiety

Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946 · see citing works

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944 · see citing works

Molecular and neuronal substrates for general anaesthetics

Rudolph, U., & Antkowiak, B. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1496 · Cited by 771 · see citing works

“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening

Schneider, G., Neidhart, W. L., Giller, T., & Schmid, G. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991004)38:19 · Cited by 715 · see citing works

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA _A Receptor

Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628 · see citing works

Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors

Brown, N. A., Kerby, J., Bonnert, T. P., Whiting, P. J., & Wafford, K. A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704795 · Cited by 603 · see citing works

Trace fear conditioning involves hippocampal α ₅ GABA _A receptors

Crestani, F., Keist, R., Fritschy, J.-M., Benke, D., Vogt, K., Prut, L., Blüthmann, H., Möhler, H., & Rudolph, U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142288699 · Cited by 528 · see citing works

GABA-based therapeutic approaches: GABAA receptor subtype functions

RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499 · see citing works

Ethanol enhances α 4 β 3 δ and α 6 β 3 δ γ-aminobutyric acid type A receptors at low concentrations known to affect humans

Wallner, M., Hanchar, H. J., & Olsen, R. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435171100 · Cited by 463 · see citing works

Reversal of pathological pain through specific spinal GABAA receptor subtypes

Knabl, J., Witschi, R., Hösl, K., Reinold, H., Zeilhofer, U. B., Ahmadi, S., Brockhaus, J., Sergejeva, M., Hess, A., Brune, K., et al. (2008) · Nature · doi:10.1038/nature06493 · Cited by 438 · see citing works

GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?

Whiting, P. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02703-x · Cited by 325 · see citing works

Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia

Lewis, D. A., Cho, R. Y., Carter, C. S., Eklund, K. E., Förster, S., Kelly, M. A., & Montrose, D. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030395 · Cited by 286 · see citing works

Novel anxiolytics that act as partial agonists at benzodiazepine receptors

Haefely, W. E., Martin, J. R., & Schoch, P. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90126-s · Cited by 277 · see citing works

Evidence for a Significant Role of α3-Containing GABA_AReceptors in Mediating the Anxiolytic Effects of Benzodiazepines

Dias, R., Sheppard, W. F. A., Fradley, R. L., Garrett, E. M., Stanley, J. L., Tye, S. J., Goodacre, S., Lincoln, R. J., Cook, S. M., Conley, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1166-05.2005 · Cited by 247 · see citing works

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

Dawson, G. R., Maubach, K. A., Collinson, N., Cobain, M., Everitt, B. J., MacLeod, A. M., Choudhury, H. I., McDonald, L. M., Pillai, G., Rycroft, W., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092320 · Cited by 241 · see citing works

Diazepam-induced changes in sleep: Role of the α1 GABA A receptor subtype

Tobler, I., Kopp, C., Deboer, T., & Rudolph, U. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111055398 · Cited by 230 · see citing works

Neurosteroids Shift Partial Agonist Activation of GABAAReceptor Channels from Low- to High-Efficacy Gating Patterns

Bianchi, M. T., & Macdonald, R. L. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10934.2003 · Cited by 206 · see citing works

Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond

Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 201 · see citing works

A schizophrenia-related sensorimotor deficit links α3-containing GABA _A receptors to a dopamine hyperfunction

Yee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201 · see citing works

TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates

Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089920 · Cited by 188 · see citing works

Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptors

Möhler, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04454.x · Cited by 137 · see citing works

Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABAA receptors

Atack, J. R., Hutson, P. H., Collinson, N., Marshall, G. R., Bentley, G., Moyes, C. R., Cook, S. M., Collins, I., Wafford, K. A., McKernan, R. M., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706056 · Cited by 135 · see citing works

Modulation of rhythmic brain activity by diazepam: GABA A receptor subtype and state specificity

Kopp, C., Rudolph, U., Löw, K., & Tobler, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306975101 · Cited by 132 · see citing works

Selective anxiolysis produced by ocinaplon, a GABA A receptor modulator

LIPPA, A. S., Czobor, P., Stark, J., Beer, B., Kostakis, E., Gravielle, M. C., Bandyopadhyay, S., Russek, S. J., Gibbs, T. T., Farb, D. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502579102 · Cited by 125 · see citing works

GABAA agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic

Krogsgaard‐Larsen, P., Frølund, B., Liljefors, T., & Ebert, B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.040 · Cited by 121 · see citing works

GABAergic analgesia: new insights from mutant mice and subtype-selective agonists

Zeilhofer, H. U., Möhler, H., & Lio, A. D. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.007 · Cited by 116 · see citing works

Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice

Knabl, J., Zeilhofer, U., Crestani, F., Rudolph, U., & Zeilhofer, H. U. (2008) · Pain · doi:10.1016/j.pain.2008.10.015 · Cited by 111 · see citing works

Both α2 and α3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm

Morris, H. V., Dawson, G. R., Reynolds, D. S., Atack, J. R., & Stephens, D. N. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04775.x · Cited by 110 · see citing works

An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABAA α5 Receptors with Cognition Enhancing Properties

Chambers, M. S., Atack, J. R., Carling, R. W., Collinson, N., Cook, S. M., Dawson, G. R., Ferris, P., Hobbs, S. C., O'Connor, D. V., Marshall, G. R., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040863t · Cited by 109 · see citing works

3-Heteroaryl-2-pyridones: Benzodiazepine Site Ligands with Functional Selectivity for α2/α3-Subtypes of Human GABAA Receptor-Ion Channels

Collins, I., Moyes, C. R., Davey, W. B., Rowley, M., Bromidge, F. A., Quirk, K., Atack, J. R., McKernan, R. M., THOMPSON, S., Wafford, K. A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110789 · Cited by 109 · see citing works

Blockade of alcohol's amnestic activity in humans by an α5 subtype benzodiazepine receptor inverse agonist

Nutt, D., Besson, M. J., Wilson, S. J., Dawson, G. R., & Lingford-Hughes, A. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.008 · Cited by 109 · see citing works

Selective, Orally Active γ-Aminobutyric Acid A α5 Receptor Inverse Agonists as Cognition Enhancers

Sternfeld, F., Carling, R. W., Jelley, R. A., Ladduwahetty, T., Merchant, K. J., Moore, K. W., Reeve, A. J., Street, L. J., O'Connor, D. V., Sohal, B., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031076j · Cited by 104 · see citing works

Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain

Munro, G., Lopez-Garcia, J. A., Rivera‐Arconada, I., Erichsen, H. K., Nielsen, E. Ø., Larsen, J. S., Ahring, P. K., & Mirza, N. R. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144568 · Cited by 103 · see citing works

Independent assembly and subcellular targeting of GABAA-receptor subtypes demonstrated in mouse hippocampal and olfactory neurons in vivo

Fritschy, J., Johnson, D. K., Möhler, H., & Rudolph, U. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00397-8 · Cited by 101 · see citing works

Zaleplon displays a selectivity to recombinant GABAA receptors different from zolipdem, zopiclone and benzodiazepines

D�mgen, K., & L�ddens, H. (1999) · Neuroscience Research Communications · doi:10.1002/(sici)1520-6769(199911/12)25:3 · Cited by 93 · see citing works

NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy

Mirza, N. R., Larsen, J. S., Mathiasen, C., Jacobsen, T. A., Munro, G., Erichsen, H. K., Nielsen, A. N., Troelsen, K. B., NIELSEN, E. O., & Ahring, P. K. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138859 · Cited by 87 · see citing works

SL651498, a GABAAReceptor Agonist with Subtype‐Selective Efficacy, as a Potential Treatment for Generalized Anxiety Disorder and Muscle Spasms

Griebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Depoortere, H., Françon, D., Avenet, P., Schoemaker, H., Evanno, Y., et al. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00241.x · Cited by 76 · see citing works

Sleep EEG changes after zolpidem in mice

Kopp, C., Rudolph, U., & Tobler, I. (2004) · Neuroreport · doi:10.1097/00001756-200410050-00031 · Cited by 64 · see citing works

In Vivo Pharmacological Characterization of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic

Foster, A. C., Pelleymounter, M. A., Cullen, M. J., Lewis, D., Joppa, M. A., Chen, T., Bozigian, H. P., Gross, R. S., & Gogas, K. R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063487 · Cited by 63 · see citing works

GABAA Receptor Subtype‐Selective Efficacy: TPA023, an α2/α3 Selective Non‐sedating Anxiolytic and α5IA, an α5 Selective Cognition Enhancer

Atack, J. R. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2007.00034.x · Cited by 53 · see citing works

Gaboxadol: in vitro interaction studies with benzodiazepines and ethanol suggest functional selectivity

Stórustovu, S. I., & Ebert, B. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01603-0 · Cited by 40 · see citing works

Pathophysiology and Pharmacology of GABAA Receptors

Möhler, H., Fritschy, J., Vogt, K. E., Crestani, F., & Rudolph, U. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_9 · Cited by 40 · see citing works

Characterization in Rats of the Anxiolytic Potential of ELB139 [1-(4-Chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a New Agonist at the Benzodiazepine Binding Site of the GABAA Receptor

Langen, B., Egerland, U., Bernöster, K., Dost, R., Unverferth, K., & Rundfeldt, C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084681 · Cited by 38 · see citing works

Sleep Disorders: Diagnosis and Therapeutics.

Parthasarathy, S. (2009) · Respiratory Care · doi:10.4187/respcare.09541737 · Cited by 32 · see citing works

GABAAReceptor Subtype-Selective Efficacy: TPA023, an α2/α3 Selective Non-sedating Anxiolytic and α5IA, an α5 Selective Cognition Enhancer

Atack, J. R. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2007.00034.x · Cited by 30 · see citing works

The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone

Atack, J. R., Pike, A., Marshall, G. R., Stanley, J. L., Lincoln, R. J., Cook, S. M., Lewis, R. T., Blackaby, W., Goodacre, S. C., McKernan, R. M., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.014 · Cited by 18 · see citing works

Behavioral profile of L‐655,708, a selective ligand for the benzodiazepine site of GABA‐A receptors which contain the α5 subunit, in social encounters between male mice

Navarro, J. F., Burón, E., & Martín‐López, M. (2004) · Aggressive Behavior · doi:10.1002/ab.20032 · Cited by 16 · see citing works

Gaboxadol. Lundbeck/Merck.

Huckle, R. (2004) · PubMed · Cited by 15 · see citing works

Functional Relevance of GABAA-Receptor Subtypes

Möhler, H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-465-0_2 · Cited by 10 · see citing works

GABAA-benzodiazepine receptors as targets for new hypnotics

Möhler, H. (2008) · Sleep Disorders · doi:10.3109/9780203091715-24 · Cited by 3 · see citing works

Ingestion of <i>Lactobacillus</i> strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · see citing works

The effect of pain on cognitive function: A review of clinical and preclinical research

Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122 · see citing works

The GABA system in anxiety and depression and its therapeutic potential

Möhler, H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 599 · see citing works

An emerging circuit pharmacology of GABAA receptors

Engin, E., Benham, R. S., & Rudolph, U. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.04.003 · Cited by 225 · see citing works

Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease

Govindpani, K., Calvo-Flores Guzmán, B., Vinnakota, C., Waldvogel, H., Faull, R., & Kwakowsky, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081813 · Cited by 208 · see citing works

GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease

Jiménez-Baladó, J., & Eich, T. S. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 185 · see citing works

Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents

Mfuh, A. M., & Larionov, O. V. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150619104007 · Cited by 159 · see citing works

Sleep, its regulation and possible mechanisms of sleep disturbances

Porkka‐Heiskanen, T., Zitting, K. ‐., & Wigren, H. ‐. (2013) · Acta Physiologica · doi:10.1111/apha.12134 · Cited by 157 · see citing works

Complex Role of Collybistin and Gephyrin in GABAA Receptor Clustering*

Saiepour, L., Fuchs, C., Patrizi, A., Sassoè-Pognetto, M., Harvey, R., & Harvey, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121368 · Cited by 137 · see citing works

TMS-EEG: A window into the neurophysiological effects of transcranial electrical stimulation in non-motor brain regions

Hill, A. T., Rogasch, N. C., Fitzgerald, P. B., & Hoy, K. E. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.006 · Cited by 128 · see citing works

The rise of a new GABA pharmacology

Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 111 · see citing works

Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

Froestl, W., Muhs, A., & Pfeifer, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121186 · Cited by 91 · see citing works

Flavonoid nutraceuticals and ionotropic receptors for the inhibitory neurotransmitter GABA

Johnston, G. A. R. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.013 · Cited by 90 · see citing works

Gut microbiota regulates key modulators of social behavior

Parashar, A., & Udayabanu, M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.002 · Cited by 88 · see citing works

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia

Coyle, J. T., Balu, D. T., Benneyworth, M. A., Basu, A. C., & Roseman, A. S. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/jcoyle · Cited by 75 · see citing works

Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism

Malaspina, P., Roullet, J., Pearl, P. L., Ainslie, G. R., Vogel, K. R., & Gibson, K. M. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.009 · Cited by 73 · see citing works

Effect of multi-session prefrontal transcranial direct current stimulation on cognition in schizophrenia: A systematic review and meta-analysis

Narita, Z. C., Stickley, A., DeVylder, J., Yokoi, Y., Inagawa, T., Yamada, Y., Maruo, K., Koyanagi, A., Oh, H. Y., Sawa, A., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.011 · Cited by 65 · see citing works

Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats

Redrobe, J. P., Elster, L., Frederiksen, K., Bundgaard, C., de Jong, I. E. M., Smith, G. P., Bruun, A. T., Larsen, P. H., & Didriksen, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2593-9 · Cited by 57 · see citing works

Neonatal NMDA receptor blockade alters anxiety- and depression-related behaviors in a sex-dependent manner in mice

Amani, M., Samadi, H., Doosti, M.-H., Azarfarin, M., Bakhtiari, A., Zolbanin, N. M., Mirzarahimi, M., & Salari, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.056 · Cited by 54 · see citing works

Developmental Changes of Glutamate and GABA Receptor Densities in Wistar Rats

Behuet, S., Cremer, J. N., Cremer, M., Palomero‐Gallagher, N., Zilles, K., & Amunts, K. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00100 · Cited by 49 · see citing works

Family-based genome-wide copy number scan identifies five new genes of dyslexia involved in dendritic spinal plasticity

Veerappa, A. M., Saldanha, M., Padakannaya, P., & Ramachandra, N. B. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.47 · Cited by 47 · see citing works

The Legacy of the Benzodiazepine Receptor

Möhler, H. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.10.008 · Cited by 43 · see citing works

Neurotransmitter systems in zebrafish model as a target for neurobehavioural studies

Verma, R., Choudhary, P. R., Nirmal, N. K., Syed, F., & Verma, R. (2022) · Materials Today: Proceedings · doi:10.1016/j.matpr.2022.07.147 · Cited by 36 · see citing works

Neuronal Glutamate and GABAA Receptor Function in Health and Disease

Moult, P. R. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371317 · Cited by 42 · see citing works

The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study

Freeman, L., García-Lorenzo, D., Bottin, L., Leroy, C., Louapre, C., Bodini, B., Papeix, C., Assouad, R., Granger, B., Tourbah, A., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24468 · Cited by 42 · see citing works

Development of corticospinal motor excitability and cortical silent period from mid-childhood to adulthood – a navigated TMS study

Säïsänen, L., Julkunen, P., Lakka, T. A., Lindi, V., Könönen, M., & Määttä, S. (2017) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2017.11.004 · Cited by 41 · see citing works

PET imaging in multiple sclerosis

Faria, D. D. P., Copray, S. C. V. M., Buchpiguel, C. A., Dierckx, R., & de Vries, E. F. J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9544-2 · Cited by 37 · see citing works

Effects of Tempeh Probiotics on Elderly With Cognitive Impairment

Handajani, Y. S., Turana, Y., Yogiara, Y., Sugiyono, S. P., Lamadong, V., Widjaja, N. T., Christianto, G. A. M., & Suwanto, A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.891773 · Cited by 35 · see citing works

Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice

Xu, N. Z., Ernst, M. C., Treven, M., Cerne, R., Wakulchik, M., Li, X., Jones, T. M., Gleason, S. D., Morrow, D., Schkeryantz, J. M., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4832-9 · Cited by 29 · see citing works

Exploring the heterogeneity of MS lesions using positron emission tomography: a reappraisal of their contribution to disability

Stankoff, B., Poirion, É., Tonietto, M., & Bodini, B. (2018) · Brain Pathology · doi:10.1111/bpa.12641 · Cited by 28 · see citing works

Filling the Gap in Understanding the Mechanism of GABAAR and Propofol Using Computational Approaches

Yuan, X., Zhang, D., Mao, S., & Wang, Q. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01290 · Cited by 28 · see citing works

Effects of an Oroxylum indicum Extract (Sabroxy®) on Cognitive Function in Adults With Self-reported Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Study

Lopresti, A. L., Smith, S. J., Majeed, M. A., & Drummond, P. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.728360 · Cited by 26 · see citing works

Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at γ-aminobutyric acid type A (GABAA) receptor

Guerrini, G., Ciciani, G., Costanzo, A., Daniele, S., Martini, C., Ghelardini, C., Mannelli, L. D. C., & Ciattini, S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.027 · Cited by 26 · see citing works

Cerebellar GABAergic correlates of cognition‐mediated verbal fluency in physiology and schizophrenia

Piras, F., Piras, F., Banaj, N., Ciullo, V., Vecchio, D., Edden, R. A. E., & Spalletta, G. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13027 · Cited by 25 · see citing works

The chronic exposure to abamectin causes spatial memory deficit and depressive behavior in mice

da Silva, W. A. M., Guimarães, A. T. B., Montalvão, M. F., Mendes, B. D. O., Rodrigues, A. S. D. L., & Malafaia, G. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.12.028 · Cited by 22 · see citing works

Physiology and Pharmacology of the GABA System: Focus on GABA Receptors

Möhler, H. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_1 · Cited by 21 · see citing works

GABA withdrawal syndrome: GABAA receptor, synapse, neurobiological implications and analogies with other abstinences

Calixto, E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.021 · Cited by 19 · see citing works

The orthosteric GABAA receptor ligand T hio‐4‐ PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors

Hoestgaard-Jensen, K., O’Connor, R. M., Dalby, N. O., Simonsen, C., Finger, B. C., Golubeva, A. V., Hammer, H., Bergmann, M., Kristiansen, U., Krogsgaard‐Larsen, P., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12340 · Cited by 17 · see citing works

Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis

Cid, M. P., Vilcaes, A. A., Rupil, L. L., Salvatierra, N. A., & Roth, G. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.005 · Cited by 17 · see citing works

An α5 GABAA Receptor Inverse Agonist, α5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures

Vinnakota, C., Govindpani, K., Tate, W. P., Peppercorn, K., Anekal, P. V., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093284 · Cited by 16 · see citing works

Family based genome‐wide copy number scan identifies complex rearrangements at 17q21.31 in dyslexics

Veerappa, A. M., Saldanha, M., Padakannaya, P., & Ramachandra, N. B. (2014) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32260 · Cited by 16 · see citing works

Auditory evoked potential: a proposal for further evaluation in children with learning disabilities

Frizzo, A. C. F. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00788 · Cited by 15 · see citing works

Altered release and uptake of gamma-aminobutyric acid in the cerebellum of dystrophin-deficient mice

da Silva, J. D. P., Campos, D. V., Nogueira-Bechara, F. M., Stilhano, R. S., Han, S. W., Sinigaglia‐Coimbra, R., Lima‐Landman, M. T. R., Lapa, A. J., & Souccar, C. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.06.001 · Cited by 15 · see citing works

A rat model of a focal mosaic expression of PCDH19 replicates human brain developmental abnormalities and behaviours

Cwetsch, A. W., Ziogas, I., Narducci, R., Savardi, A., Bolla, M., Pinto, B., Perlini, L. E., Bassani, S., Passafaro, M., & Cancedda, L. (2022) · Brain Communications · doi:10.1093/braincomms/fcac091 · Cited by 14 · see citing works

Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [ 11 C]Ro15-4513 microPET study

Bertelsen, F., Landau, A. M., Vase, K. H., Jacobsen, J., Scheel‐Krüger, J., & Møller, A. (2017) · Brain Research · doi:10.1016/j.brainres.2017.12.018 · Cited by 13 · see citing works

Combined oral contraceptives and mental health: Are adolescence and the gut-brain axis the missing links?

Kheloui, S., Smith, A. M., & Ismail, N. (2022) · Frontiers in neuroendocrinology (Print) · doi:10.1016/j.yfrne.2022.101041 · Cited by 13 · see citing works

Studies of properties of ?Pain Networks? as predictors of targets of stimulation for treatment of pain

Liu, C. C., Franaszczuk, P. J., Crone, N. E., Jouny, C. C., & Lenz, F. A. (2011) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2011.00080 · Cited by 12 · see citing works

Chronic Alcohol Treatment-Induced GABA-Aα5 Histone H3K4 Trimethylation Upregulation Leads to Increased GABA-Aα5 Expression and Susceptibility to Alcohol Addiction in the Offspring of Wistar Rats

Zeng, K., Xie, A., Zhang, X., Zhong, B., Liu, X., & Hao, W. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00468 · Cited by 12 · see citing works

Diversity matters: combinatorial information coding by GABAA receptor subunits during spatial learning and its allosteric modulation

Szodorai, E., Bampali, K., Romanov, R. A., Kasper, S. F., Hökfelt, T. G. M., Ernst, M. C., Lübec, G., & Harkany, T. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.07.003 · Cited by 11 · see citing works

Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol

Soria, C., Remedi, C., Núñez, D., D’Alessio, L., & Ej, R. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007231 · Cited by 11 · see citing works

Glycine Promotes the Survival of a Subpopulation of Neural Stem Cells

Bekri, A., & Drapeau, P. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00068 · Cited by 11 · see citing works

Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry

Sfera, A., Thomas, K. G., Sasannia, S., Anton, J. J., Andronescu, C. V., Garcia, M., Sfera, D. O., Cummings, M. A., & Kozlakidis, Z. (2022) · Reports — Medical Cases Images and Videos · doi:10.3390/reports5020022 · Cited by 10 · see citing works

Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor

Palner, M., Beinat, C., Banister, S. D., Zanderigo, F., Park, J. H., Shen, B., Hjørnevik, T., Jung, J. H., Lee, B. C., Kim, S. E., et al. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0235-2 · Cited by 10 · see citing works

Potential of nafimidone derivatives against co‐morbidities of epilepsy: In vitro, in vivo, and in silico investigations

Sarı, S., Barut, B., Marcinkowska, M., Sabuncuoğlu, S., Avci, A., Aslan, E. K., Özel, A., & Siwek, A. (2021) · Drug Development Research · doi:10.1002/ddr.21858 · Cited by 9 · see citing works

GABA-cannabinoid interplays in the dorsal hippocampus and basolateral amygdala mediate morphine-induced amnesia

Sharifi, K. A., Rezayof, A., Alijanpour, S., & Zarrindast, M. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.01.012 · Cited by 8 · see citing works

The dystrophin gene and cognitive function in the general population

Vojinović, D., Adams, H. H. H., van der Lee, S. J., Ibrahim‐Verbaas, C. A., Brouwer, R. W. W., van den Hout, M. C. G. N., Oole, E., van Rooij, J., Uitterlinden, A. G., Albert Hofman, D., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.183 · Cited by 8 · see citing works

Antinociceptive Effects of α2/α3-Subtype-Selective GABAA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral Specificity

Lewter, L. A., Woodhouse, K. L., Tiruveedhula, V. V. N. P. B., Cook, J. M., & Li, J. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002070 · Cited by 7 · see citing works

A multi-dosing regimen to enhance the spatial memory of normal rats with α5-containing GABAA receptor negative allosteric modulator L-655,708

Yuan, C., Gao, A., Xu, Q., Zhang, B., Xue, R., Dou, Y., & Yu, C. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05951-3 · Cited by 6 · see citing works

Concurrent transcranial magnetic stimulation and electroencephalography measures are associated with antidepressant response from rTMS treatment for depression

Bailey, N. W., Hoy, K. E., Sullivan, C. M., Allman, B., Rogasch, N. C., Daskalakis, Z. J., & Fitzgerald, P. B. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100612 · Cited by 5 · see citing works

The DNA demethylase TET1 modifies the impact of maternal folic acid status on embryonic brain development

Chen, L., van der Veer, B. K., Chen, Q., Tsaniras, S. C., Brangers, W., Kwak, H. H. M., Khoueiry, R., Lei, Y., Cabrera, R. M., Gross, S. S., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00316-1 · Cited by 6 · see citing works

Effect of Yi-nao-jie-yu decoction on γ-aminobutyric acid type A receptor in the hippocampus and serum inflammatory factors in a rat model of poststroke anxiety

Zhang, W., Zhao, R., Li, X., Cui, X., Zhao, Z., Mao, Y., Wu, F., & Tang, Q. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s115116 · Cited by 5 · see citing works

Relationship between age and remimazolam dose required for inducing loss of consciousness in older surgical patients

Song, J.-C., Wang, X.-X., Fu, X., Chen, W., Tang, S.-H., Deng, F., Yang, H., & Liu, W. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1331103 · Cited by 6 · see citing works

Fewer GABAergic interneurons, heightened anxiety and decreased high-frequency electroencephalogram components in Bronx waltzer mice, a model of hereditary deafness

Matsuda, Y., Inoue, Y., Izumi, H., Kaga, M., Inagaki, M., & Goto, Y. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.006 · Cited by 5 · see citing works

Bacopa monnieri for cognitive health—a review of molecular mechanisms of action

Purusothaman, D., Chalichem, N. S. S., Bethapudi, B., Murugan, S., & Mundkinajeddu, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00003-3 · Cited by 4 · see citing works

PET Imaging in Multiple Sclerosis

van der Weijden, C. W. J., Meilof, J., & de Vries, E. D. (2020) · PET and SPECT in Neurology · doi:10.1007/978-3-030-53168-3_33

Gabra5-gene haplotype block associated with behavioral properties of the full agonist benzodiazepine chlordiazepoxide

Clément, Y., Prut, L., Saurini, F., Mineur, Y. S., Guisquet, A. M. L., Védrine, S., Andres, C. R., Vodjdani, G., & Belzung, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.041 · Cited by 4 · see citing works

Different effects of etomidate and propofol on memory in immature rats

Jiang, Y., Ni, X.-Q., Xiong, W.-W., Wang, H., Tan, Y., Huang, Z., & Yao, X. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.901968 · Cited by 3 · see citing works

Effect of synthetic steroids on GABAA receptor binding in rat brain

Rey, M., Veleiro, A. S., Ghini, A. A., Kruse, M. S., Burton, G., & Coirini, H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.082 · Cited by 3 · see citing works

Biological mechanism of sex differences in mental rotation: Evidence from multimodal MRI, transcriptomic and receptor/transporter data

Long, H.-X., Wu, H., Sun, C., Xu, X.-L., Yang, X.-H., Xiao, J., Lv, M.-Q., Chen, Q.-J., & Fan, M. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120955 · Cited by 2 · see citing works

Reflections on More Than 30 Years Association with Hanns

Bowery, N. G. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2014.11.001 · Cited by 1 · see citing works

Targeting Cognitive Deficits in Schizophrenia via GABAA Receptors

Rudolph, U., & Möhler, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00017-3 · Cited by 1 · see citing works

Prolonged persistent anterograde amnesia due to chronic self-prescribed midazolam therapy for insomnia

Galassi, L., Facchinetti, F., & FAITELLI, B. (2025) · Minerva Psychiatry · doi:10.23736/s2724-6612.25.02612-0 · Cited by 1 · see citing works

An Oppositional Tolerance Account for Potential Cognitive Deficits Caused by the Discontinuation of Antidepressant Drugs

Beste, C., Stock, A., Colzato, L. S., Zhang, W., & Walter, H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1520-4784 · Cited by 1 · see citing works

An Investigation of the Role of GABAb Ligands on Cued and Contextual Fear Conditioning

Heaney, C. F. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/4332555

A Comparison of the Effects of Different Doses of GABAB Receptor Ligands on Spatial Learning and Memory and Memory Flexibility

Heaney, C. F. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/7645911

Benzodiazepine receptor agonists and sleep

Möhler, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.20037-6

Repeated Electroconvulsive Shock Transiently Affects Cognition and Neurometabolism in Mice

Sarawagi, A., Sinha, S., & Patel, A. B. (2025) · Journal of Ect · doi:10.1097/yct.0000000000001166

Benzodiazepine Receptor Agonists and Sleep

Möhler, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378610-4.00123-6

BindingDB Entry 50042867: Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at¿-aminobutyric acid type A (GABA(A)) receptor.

BindingDB (2013) · UC San Diego · doi:10.7270/q2kd208c

GABAA receptor diversity and pharmacology

Möhler, H. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0284-3 · Cited by 359 · see citing works

Functional Relevance of GABAA-Receptor Subtypes

Möhler, H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-465-0_2 · Cited by 10 · see citing works

Differential roles of GABA Receptors in Anxiety

Möhler, H. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199934959.003.0042 · Cited by 1 · see citing works

Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptors

Möhler, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04454.x · Cited by 137 · see citing works

Pathophysiology and Pharmacology of GABAA Receptors

Möhler, H., Fritschy, J., Vogt, K. E., Crestani, F., & Rudolph, U. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_9 · Cited by 40 · see citing works